Clinical Trial Update: Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex [Phase 3]

View source ↗

Summary

Phase 3 trial update validating patient-reported outcome measures in participants with nontuberculous mycobacterial pulmonary disease caused by Mycobacterium av…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Infection
• Nontuberculous Mycobacterial Pulmonary Disease

Drugs mentioned

• Arikayce (amikacin liposome inhalation suspension)

Snippet

Sponsor: Insmed Incorporated | Conditions: Mycobacterium Infections, Nontuberculous | Phase 3 | Status: COMPLETED | Results posted: 2024-06-28